Commentary on: Effects of cinnamon consumption on glycemic status, lipid profile and body composition in type 2 diabetic patients

International Journal of Preventive Medicine

Volumn 4, Issue 5, 2013, Pages 618-619

  Nasri, Hamid ^a   Madihi, Yahya ^b   Marikhi, Alireza ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; LIPID; TRIACYLGLYCEROL;

BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY MASS; BODY WEIGHT; CINNAMON CONSUMPTION; CLINICAL EFFECTIVENESS; DIABETIC NEPHROPATHY; DIET THERAPY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; LETTER; LIPID BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RENAL PROTECTION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 84879559616     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: None     Document Type: Letter

References (19)

1. Vafa M, Mohammadi F, Shidfar F, Sormaghi MS, Heidari I, Golestan B, et al. Effects of cinnamon consumption on glycemic status, lipid profile and body composition in type 2 diabetic patients. Int J Prev Med 2012;3:531-536.
2. Mishra A, Bhatti R, Singh A, Singh Ishar MP. Ameliorative effect of the cinnamon oil from Cinnamomum zeylanicum upon early stage diabetic nephropathy. Planta Med 2010;76:412-417.
3. Ullah N, Khan MA, Khan T, Ahmad W. Bioactive traditional plant Cinnamomum zeylanicum successfully combat against nephrotoxic effects of aminoglycosides. Bangladesh J Pharmacol 2013;8:15-21.
4. Tavafi M. Inhibition of gentamicin-induced renal tubular cell necrosis. J Nephropathology 2012;1:83-86.
5. Kadkhodaee M. Erythropoietin; bright future and new hopes for an old drug. J Nephropathology 2012;1:81-82.
6. Rafieian-Kopaei M, Nasri H, Nematbakhsh M, Baradaran A, Gheissari A, Rouhi H, et al. Erythropoietin ameliorates gentamicin-induced renal toxicity: A biochemical and histopathological study. J Nephropathology 2012;1:109-116.
7. Amini FG, Rafieian-Kopaei M, Nematbakhsh M, Baradaran A, Nasri H. Ameliorative effects of metformin on renal histologic and biochemical alterations of gentamicin-induced renal toxicity in Wistar rats. J Res Med Sci 2012;17:621-625.
8. Rafieian-Kopaei M, Baradaran A, Merrikhi A, Nematbakhsh M, Madihi Y, Nasri H. Efficacy of co-administration of garlic extract and metformin for prevention of gentamicin-renal toxicity in wistar rats: A biochemical study. Int J Prev Med 2013;4:258-264.
9. Tolouian R, Hernandez GT. Prediction of diabetic nephropathy: The need for a sweet biomarker. J Nephropathology 2013;2:4-5.
10. Rahimi Z. ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy. J Nephropathology 2012;1:143-151.
11. Rouhi H, Ganji F. Effect of n-acetyl cysteine on serum lipoprotein(a) and proteinuria in type 2 diabetic patients. J Nephropathology 2013;1:61-66.
12. Baradaran A. Lipoprotein(a), type 2 diabetes and nephropathy; the mystery continues. J Nephropathology 2012;1:126-129.
13. Tavafi M. Diabetic nephropathy and antioxidants. J Nephropathology 2013;2:20-27.
14. Khajehdehi P. Turmeric: Reemerging of a neglected Asian traditional remedy. J Nephropathology 2012;1:17-22.
15. Gheissari A, Javanmard SH, Shirzadi R, Amini M, Khalili N. The effects of blocking Angiotensin receptors on early stages of diabetic nephropathy. Int J Prev Med 2012;3:477-482.
16. Gheissari A, Hemmatzadeh S, Merrikhi A, Fadaei Tehrani S, Madihi Y. Chronic kidney disease in children: A report from a tertiary care center over 11 years. J Nephropathology 2012;1:177-182.
17. Gheissari A, Mehrasa P, Merrikhi A, Madihi Y. Acute kidney injury: A pediatric experience over 10 years at a tertiary care center. J Nephropathology 2012;1:101-108.
18. Nematbakhsh M, Pezeshki Z, Moaeidi B, Eshraghi-Jazi F, Talebi A, Nasri H, et al. Protective role of silymarin and deferoxamine against iron dextran-Induced renal iron deposition in male rats. Int J Prev Med 2013;4:286-291.
19. Akilen R. Effects of cinnamon consumption on glycemic status, lipid profile and body composition in type 2 diabetic patients. Int J Prev Med 2013;4:379-380.